BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,375,816 | -17.2% | 89,449 | +0.0% | 0.01% | -18.8% |
Q2 2023 | $4,074,953 | +13.0% | 89,441 | +0.6% | 0.02% | 0.0% |
Q1 2023 | $3,605,573 | -19.4% | 88,895 | +1.3% | 0.02% | -30.4% |
Q4 2022 | $4,472,721 | +0.8% | 87,752 | +6.5% | 0.02% | -11.5% |
Q3 2022 | $4,436,000 | -12.2% | 82,359 | +5.2% | 0.03% | -21.2% |
Q2 2022 | $5,052,000 | -6.3% | 78,314 | +13.0% | 0.03% | -5.7% |
Q1 2022 | $5,394,000 | -5.3% | 69,318 | +4.8% | 0.04% | -10.3% |
Q4 2021 | $5,696,000 | +9.5% | 66,147 | +2.6% | 0.04% | -9.3% |
Q3 2021 | $5,204,000 | -1.9% | 64,473 | -1.9% | 0.04% | -12.2% |
Q2 2021 | $5,307,000 | -8.6% | 65,696 | -4.3% | 0.05% | -22.2% |
Q1 2021 | $5,808,000 | +14.2% | 68,668 | +8.7% | 0.06% | -6.0% |
Q4 2020 | $5,087,000 | -10.1% | 63,186 | -11.0% | 0.07% | -28.7% |
Q3 2020 | $5,658,000 | -8.1% | 70,970 | +0.6% | 0.09% | -6.9% |
Q2 2020 | $6,157,000 | +12.8% | 70,513 | +1.6% | 0.10% | -15.8% |
Q1 2020 | $5,460,000 | -9.9% | 69,411 | -1.6% | 0.12% | +25.0% |
Q4 2019 | $6,060,000 | +82.6% | 70,567 | +86.4% | 0.10% | -17.9% |
Q3 2019 | $3,319,000 | +3.6% | 37,851 | -2.9% | 0.12% | -1.7% |
Q2 2019 | $3,203,000 | +5.0% | 38,998 | +4.2% | 0.12% | -4.0% |
Q1 2019 | $3,051,000 | +20.9% | 37,439 | -2.1% | 0.12% | -8.1% |
Q4 2018 | $2,524,000 | -15.2% | 38,244 | -0.6% | 0.14% | +1.5% |
Q3 2018 | $2,975,000 | +750.0% | 38,491 | +713.9% | 0.13% | +600.0% |
Q2 2018 | $350,000 | +26.4% | 4,729 | +8.3% | 0.02% | +11.8% |
Q1 2018 | $277,000 | -1.4% | 4,365 | +0.7% | 0.02% | 0.0% |
Q4 2017 | $281,000 | +92.5% | 4,334 | +91.3% | 0.02% | +183.3% |
Q3 2017 | $146,000 | – | 2,266 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |